|
Characteristic
|
Cases
|
Disease-specific survival (DSS) (%)
|
P#
|
Disease-free survival (DFS) (%)
|
P#
|
|---|
|
3-year DSS
|
5-year DSS
|
3-year DFS
|
5-year DFS
|
|---|
|
Gender
| | | |
0.450
| | |
0.830
|
|
Male
|
135
|
60.6
|
50.8
| |
49.2
|
37.1
| |
|
Female
|
49
|
58.2
|
44.5
| |
46.7
|
34.9
| |
|
Age
| | | |
0.096
| | |
0.382
|
|
≤ 60
|
104
|
64.5
|
53.6
| |
53.5
|
40.6
| |
|
> 60
|
80
|
54.3
|
43.8
| |
42.3
|
31.3
| |
|
Location
| | | |
0.228
| | |
0.500
|
|
Upper
|
40
|
53.9
|
40.0
| |
44.0
|
34.9
| |
|
Middle
|
100
|
59.8
|
50.7
| |
48.2
|
34.4
| |
|
Lower
|
44
|
65.6
|
52.3
| |
53.4
|
43.1
| |
|
Differentiation
| | | |
0.217
| | |
0.048
|
|
Grade 1
|
46
|
68.8
|
59.6
| |
61.6
|
49.9
| |
|
Grade 2
|
92
|
61.5
|
47.8
| |
47.4
|
33.2
| |
|
Grade 3
|
46
|
47.2
|
41.5
| |
37.5
|
30.0
| |
|
pT category
| | | |
0.064
| | |
0.098
|
|
T1-2
|
44
|
67.8
|
61.4
| |
57.0
|
48.3
| |
|
T3-4
|
140
|
57.4
|
45.4
| |
45.9
|
32.9
| |
|
pN category
| | | |
0.000
| | |
0.000
|
|
N0
|
100
|
76.9
|
65.7
| |
69.2
|
53.6
| |
|
N1-3
|
84
|
40.0
|
30.0
| |
25.0
|
17.3
| |
|
Pathological staging
| | | |
0.000
| | |
0.000
|
|
I
|
13
|
92.3
|
80.8
| |
92.3
|
71.2
| |
|
II
|
92
|
72.3
|
61.8
| |
62.8
|
50.1
| |
|
III
|
79
|
40.2
|
29.6
| |
25.4
|
15.8
| |
|
GSTM3 expression
| | | |
0.132
| | |
0.016
|
|
Low
|
91
|
56.2
|
46.0
| |
39.2
|
26.8
| |
|
High
|
93
|
64.6
|
52.8
| |
57.4
|
45.1
| |
- #Kaplan-Meier method (log-rank test)
